• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Estrogen withdrawal associated with perimenopausal depression

byDenise PongandLeah Hawkins Bressler, MD, MPH
May 31, 2015
in Obstetrics, Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Women with a history of perimenopausal depression experienced an increase in severity of depression after estrogen withdrawal.

2. These women reported avoidance of socialization, sleep disturbances, and decreased motivation following discontinuation of hormone therapy.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Menopause denotes the permanent cessation of menstruation and is diagnosed when a woman experiences amenorrhea for 12 consecutive months. The average age of menopause in the United States is 51.2 years. Prior to menopause, women first enter the climacteric transition with a phase known as perimenopause, the average age of which is 46 years. During perimenopause, women may experience menstrual irregularities and symptoms such as hot flashes, sleep disturbances, vaginal dryness and mood changes. These symptoms are thought to be due to hormonal changes that occur when ovarian follicles are depleted. Often used to treat vasomotor symptoms, hormone replacement therapy (HRT) with estradiol can also improve mood among women experiencing perimenopausal depression (PMD). To date, the relationship between menopausal hormone changes and mood disturbances has not been well characterized. In the present work, the authors evaluated whether withdrawal of estradiol hormonal replacement therapy is linked to depression and whether this relationship is influenced by history of perimenopausal depression. Findings demonstrated that HRT withdrawal was associated with an increased severity of depressive symptoms among women with prior PMD. In light of the finding that estrogen withdrawal may affect women with past PMD differentially, clinicians should take special care to monitor the mental health of women in this category upon cessation of HRT.

Strengths of this study included randomized, double-blinded, placebo-controlled, parallel design trial. Limitations included small sample size, which may limit power, baseline differences in depressive symptoms between women with and without history of PMD and a short trial period. Further evaluation of longer-term outcomes in larger populations is warranted.

Click to read the study in JAMA Psychiatry

Relevant Reading: Hormones and menopausal status as predictors of depression in women in transition to menopause

RELATED REPORTS

Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

The Scan by 2 Minute Medicine®: The Fight Against Childhood Obesity, Prioritizing Mental Health, The Rise of XBB1.5, and Choose Your Chocolates Wisely

In-Depth [randomized controlled trial]: This randomized trial evaluated the impact of discontinuance of HRT on depressive symptoms in postmenopausal women with and without histories of PMD. All participants received 100 ug/d estradiol transdermally for 3 weeks prior to randomization to continue estradiol (n = 27) or receive placebo (n = 29).  The primary outcome of interest was depressive symptoms, as assessed by the Epidemiologic Studies Depression Scale (CES-D), Hamilton Depression Rating Scale (HDRS), Beck Depression Inventory (BDI) and visual analog scale (VAS). Secondary outcomes were the presence and severity of vasomotor symptoms.

Among women with past PMD, those randomized to placebo experienced increases in CES-D and HDRS depression severity ratings (p < 0.001 for both) and BDI scores (p = 0.05). They also experienced increased scores in depression (p = 0.01), avoidance of socializing (p = 0.03), early morning awakening (p = 0.04), and lack of motivation (p = 0.02) as measured by the VAS. There were no significant differences in vasomotor symptoms between groups.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: depressionhormone replacement therapymenopause
Previous Post

Newer oral contraceptives linked with higher blood clot risk

Next Post

No improvement in maternal vaccine hesitancy with physician-targeted intervention

RelatedReports

Romosozumab significantly increases bone mineral density in postmenopausal women
Chronic Disease

Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk

January 30, 2023
#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer
StudyGraphics

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

January 24, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Fight Against Childhood Obesity, Prioritizing Mental Health, The Rise of XBB1.5, and Choose Your Chocolates Wisely

January 25, 2023
Certain financial incentive programs may promote increased physical activity
Chronic Disease

Physical activity may be helpful in treating depressive symptoms in children and adolescents

January 18, 2023
Next Post
No improvement in maternal vaccine hesitancy with physician-targeted intervention

No improvement in maternal vaccine hesitancy with physician-targeted intervention

Stronger alcohol policies linked to decreased youth drinking

Stronger alcohol policies linked to decreased youth drinking

Medical-legal family specialist program shows benefits for infants

Medical-legal family specialist program shows benefits for infants

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options